Exact Mass: 346.1084134000001
Exact Mass Matches: 346.1084134000001
Found 271 metabolites which its exact mass value is equals to given mass value 346.1084134000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Nifedipine
Nifedipine has been formulated as both a long- and short-acting 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nifedipine prevents calcium-dependent myocyte contraction and vasoconstriction. A second proposed mechanism for the drugs vasodilatory effects involves pH-dependent inhibition of calcium influx via inhibition of smooth muscle carbonic anhydrase. Nifedipine is used to treat hypertension and chronic stable angina. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Miraxanthin V
Reduced-(S)-usnate
Muscomin
Muscomin is found in herbs and spices. Muscomin is isolated from Muscari comosum (tassel hyacinth). Isolated from Muscari comosum (tassel hyacinth). Muscomin is found in herbs and spices.
meta-O-Dealkylated flecainide lactam
meta-O-Dealkylated flecainide lactam is a metabolite of flecainide. Flecainide acetate is a class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias (abnormal fast rhythms of the heart). It is used to treat a variety of cardiac arrhythmias including paroxysmal atrial fibrillation (episodic irregular heartbeat originating in the upper chamber of the heart), paroxysmal supraventricular tachycardia (episodic rapid but regular heartbeat originating in the atrium), and ventricular tachycardia (rapid rhythms of the lower chambers of the heart). (Wikipedia)
M-Nifedipine
2,6-Dimethyl-4-(2-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester
Tenatoprazole
C16H18N4O3S (346.1099558000001)
2,6-Dihydroxy-4,3-dimethoxy-4,5-methylenedioxydihydrochalcone
Inumakilactone B
A diterpene lactone isolated from Podocarpus latifolius and has been shown to exhibit inhibitory activity against activator protein 1 (AP-1).
(+)-(5R,6R)-5-cyano-5-beta-D-glucopyranosyloxy-6-hydroxy-4-methoxy-1-methyl-5,6-dihydro-2-pyridone|epiacalyphin
(9-acetoxy-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl) acetate
1,2,3,6,8-pentamethoxy xanthone|1,2,3,6,8-pentamethoxy-xanthen-9-one|1.3.6.7.8-Pentamethoxyxanthon
methyl 5-((2E)-1-hydroxy-3-phenylprop-2-enylidene)-2,3-dimethoxy-4-oxocyclopent-2-enecarboxylate|stigmahamone II
2-(3-hydroxy-3-methylbutyl)-1,3,5,6-tetrahydroxyxanthone
methyl 4-(2,4-dihydroxy-6-methyl-benzoyl)oxy-2-hydroxy-3,6-dimethyl-benzoate
2,2-(Oxydimethylene)bis[6-hydroxy-3,5-dimethyl-p-benzoquinone]
Ventiloquinone B|ventiloquinone-B|ventiloquinone-M dimethyl ether
6,7-Dimethoxy-8-(1-acetoxy-3-methyl-2-oxo-3-butenyl)-2H-1-benzopyran-2-one
3,5-Dihydroxy-2-(3,4-dimethoxyphenyl)-7-methoxy-2,3-dihydro-4H-1-benzopyran-4-one
rel-(1aR,2R,3R,7bS)-1a,2,3,7b-tetrahydro-2,3-dihydroxy-5-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-7H-oxireno[f][1]benzopyran-7-one
(3S)-3,5,7-trihydroxyl-6-methyl-8-methoxyl-3-(4-hydroxylbenzyl)chroman-4-one|polygonatone B
(3R)-7-hydroxy-6,2,3-trimethoxyisoflavan-1,4-quinone
3?,7-dimethoxy-8-methyl-4?,5,7-trihydroxyflavanone
3?,4?-dimethoxy-8-methyl-5,6,7-trihydroxyflavanone
methyl 2-((2R,3R,4S)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)chroman-4-yl)acetate
(2S,3R)-methyl 7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydrobenzofuran-5-carboxylate|norcurlignan
(3R)-8-hydroxy-7,4?6-trimethoxyisoflavan-2,5-quinone|abruquinone I
4-(2,4-dihydroxy-3,6-dimethylbenzoyloxy)-2-hydroxy-3,6-dimethylbenzoic acid
2-O-Ac-(R)-Heraclenol|8-(2-acetoxy-3-hydroxy-3-methylbutoxy)psoralen|9-(2-acetoxy-3-hydroxy-3-methyl-butoxy)-furo[3,2-g]chromen-7-one|Heraclenol-monoacetat
2,3-Dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxybenzofuran-5-carboxylic acid
cremastranone
A homoisoflavonoid that is 2,3-dihydro-4H-chromen-4-onethat is substituted by hydroxy groups at positions 5 and 7, a methoxy group at position 6, and a 3-hydroxy-4-methoxybenzyl group at position 3. It has been isolated from various plants, including the bulb of Cremastra appendiculata.
2-O-acetyloxypeucedanin hydrate|oxypeucedanin hydrate 2-monoacetate
(3S)-3-(3,4-dihydroxybenzyl)-5-hydroxy-6,7-dimethoxychroman-4-one|scillavone B
PSQNZFFDWLQECV-UHFFFAOYSA-N
5,3-Dihydroxy-6,7,4-trimethoxyflavanone is a natural product found in Vitex rotundifolia with data available.
nifedipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
methyl 5-hydroxy-2-(2-hydroxy-6-methoxy-4-methylbenzoyl)-3-methoxybenzoate
4-(2,4-dihydroxy-3,5-dimethylbenzoyl)oxy-2-hydroxy-3,5-dimethylbenzoic acid
6,7-dihydroxy-5-[3-hydroxy-2-(methoxymethyl)-5-methylphenoxy]-4-methyl-3H-2-benzofuran-1-one
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3,5-dimethoxybenzoate
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3,5-dimethoxybenzoate
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3,5-dimethoxybenzoate_major
ethyl 2-amino-3-nitro-4-thiophen-2-yl-5,6,7,8-tetrahydronaphthalene-1-carboxylate
Methyl 4,5-diacetoxy-8-methoxy-6-methyl-2-naphthoate
Vatalanib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Tenatoprazole
C16H18N4O3S (346.1099558000001)
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor
2-ethylhexyl 2-(2,4-dichlorophenoxy)propionate
C17H24Cl2O3 (346.11024139999995)
[3-[[(2,4,6-trimethylphenyl)sulfonylhydrazinylidene]methyl]phenyl]boronic acid
C16H19BN2O4S (346.11585240000005)
3-(3-Hydroxy-4-methoxybenzyl)-5,7-dihydroxy-6-methoxychroman-4-one
4-[[[2-(4-Fluorophenyl)ethylamino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester
(2R)-2-{[(4-Fluoro-3-methylphenyl)sulfonyl]amino}-N-hydroxy-2-tetrahydro-2H-pyran-4-ylacetamide
C14H19FN2O5S (346.09986560000004)
1-[4-[4-(4-Chloro-2-hydroxy-phenoxy)phenyl]piperazin-1-yl]ethanone
meta-O-Dealkylated flecainide lactam
meta-O-Dealkylated flecainide lactam is a metabolite of flecainide. Flecainide acetate is a class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias (abnormal fast rhythms of the heart). It is used to treat a variety of cardiac arrhythmias including paroxysmal atrial fibrillation (episodic irregular heartbeat originating in the upper chamber of the heart), paroxysmal supraventricular tachycardia (episodic rapid but regular heartbeat originating in the atrium), and ventricular tachycardia (rapid rhythms of the lower chambers of the heart). (Wikipedia)
(S,E)-4-(2-((3,4-Dihydroxyphenethyl)imino)ethylidene)-1,2,3,4-tetrahydropyridine-2,6-dicarboxylic acid
(6R)-2-acetyl-6-(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)-3-hydroxy-6-methylcyclohexa-2,4-dien-1-one
2-(3,4-dimethoxyphenyl)-1-[5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]ethanone
6-(2-chlorophenyl)-N-(3-pyridinylmethyl)-4-quinazolinamine
(E)-2-cyano-3-(1-methylindol-3-yl)-N-(3-nitrophenyl)prop-2-enamide
N-(3-fluorophenyl)-2-(9-oxo-10-acridinyl)acetamide
C21H15FN2O2 (346.11175019999996)
2-(1-Ethoxycarbonyl-4-piperidinyl)-1,3-dioxo-5-isoindolecarboxylic acid
4-[2-(3,4-Dimethoxyphenyl)ethylamino]-3-nitrobenzoic acid
5-[Anilino(oxo)methyl]-4-methyl-2-(1-oxopropylamino)-3-thiophenecarboxylic acid methyl ester
6-(3-chlorophenyl)-N-(3-pyridinylmethyl)-4-quinazolinamine
(4E)-6-carboxy-4-[2-[2-(3,4-dihydroxyphenyl)ethylazaniumylidene]ethylidene]-2,3-dihydro-1H-pyridine-2-carboxylate
4-(2,4-Dihydroxy-3,5-dimethylbenzoyl)oxy-2-hydroxy-3,5-dimethylbenzoic acid
6,7-dihydroxy-5-[3-hydroxy-2-(methoxymethyl)-5-methylphenoxy]-4-methyl-3H-2-benzofuran-1-one
2,6-Dimethyl-4-(2-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester
NPEC-caged-dopamine
NPEC-caged-dopamine is a caged version of dopamine. NPEC-caged-Dopamine was used by applying focal photolysis with UV light (360 nm) to releases dopamine, which leads to D1 receptor activation[1].
4-(2,4-dihydroxy-3,6-dimethylbenzoyloxy)-2-methoxy-6-methylbenzoic acid
2-(3,4-dihydroxyphenyl)-5,6,7-trimethoxy-2,3-dihydro-1-benzopyran-4-one
3-hydroxy-2-methyl-4-({7-oxofuro[3,2-g]chromen-4-yl}oxy)butan-2-yl acetate
(2s)-5-hydroxy-2-(2-hydroxy-4,5-dimethoxyphenyl)-7-methoxy-2,3-dihydro-1-benzopyran-4-one
methyl 3-hydroxy-2-(2-hydroxy-6-methoxy-4-methylbenzoyl)-5-methoxybenzoate
(2r)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-2,3-dihydro-1-benzopyran-4-one
5,7-dihydroxy-3-(2,4,5-trimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(3s)-3-(2,6-dimethoxyphenyl)-4-hydroxy-6-(hydroxymethyl)-5-methoxy-3h-2-benzofuran-1-one
2-(3,4-dimethoxyphenyl)-5,7-dihydroxy-3-methoxy-2,3-dihydro-1-benzopyran-4-one
11,17-dimethoxy-4,6-dimethyl-5,13,15-trioxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3(8),11,16-tetraene-2,9-dione
1-(6,7-dimethoxy-2-oxochromen-8-yl)-3-methyl-2-oxobut-3-en-1-yl acetate
(3r)-3-{6-[(2r)-2-hydroxypropyl]-4-oxopyran-3-yl}-4,6-dimethoxy-3h-2-benzofuran-1-one
(3s)-5,7-dihydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-2,3-dihydro-1-benzopyran-4-one
3-[(3,4-dihydroxyphenyl)methyl]-5-hydroxy-6,7-dimethoxy-2,3-dihydro-1-benzopyran-4-one
5,7-dihydroxy-2-(2,4,6-trimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(1s,2r,4r,5r,10s,11r,13s,14r,15r,18r)-5-ethenyl-14-hydroxy-10,15-dimethyl-3,6,12,17-tetraoxahexacyclo[8.7.1.0²,⁴.0⁴,⁹.0¹¹,¹³.0¹⁵,¹⁸]octadec-8-ene-7,16-dione
(2s)-5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
5,7-dihydroxy-3-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2,3-dihydro-1-benzopyran-4-one
(3s)-5,7-dihydroxy-3-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2,3-dihydro-1-benzopyran-4-one
2,3-dihydro-7-o-demethylrobustigenin
{"Ingredient_id": "HBIN004016","Ingredient_name": "2,3-dihydro-7-o-demethylrobustigenin","Alias": "NA","Ingredient_formula": "C18H18O7","Ingredient_Smile": "NA","Ingredient_weight": "346.336","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8948","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-5,2'-dihydroxy-7,4',5'-trimethoxyflavanone
{"Ingredient_id": "HBIN006752","Ingredient_name": "(2s)-5,2'-dihydroxy-7,4',5'-trimethoxyflavanone","Alias": "NA","Ingredient_formula": "C18H18O7","Ingredient_Smile": "COC1=CC(=C2C(=O)CC(OC2=C1)C3=CC(=C(C=C3O)OC)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6158","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}